Paula I Gonzalez-Ericsson

38PUBLICATIONS
250CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Oct 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.

Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann

|Sep 19, 2025
Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner.

Sarah C Reed, Chad R Potts, Leo Y Luo

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Jan 13, 2025
In Situ Detection of Individual Classic MHC-I Gene Products in Cancer.

Paula I Gonzalez-Ericsson, Susan R Opalenik, Violeta Sanchez

Pageof 7